| Evaluation of humoral immunity profiles to identify heart recipients at risk for development of severe infections: a multicenter prospective study E Sarmiento, M Jaramillo, L Calahorra, J Fernandez-Yañez, ... The Journal of Heart and Lung Transplantation 36 (5), 529-539, 2017 | 36 | 2017 |
| Regulatory Cells in Multiple Sclerosis: From Blood to Brain L Calahorra, C Camacho- Toledano, MP Serrano- Regal, MC Ortega, ... Biomedicines 10 (2), 335-362, 2022 | 33 | 2022 |
| Early intravenous immunoglobulin replacement in hypogammaglobulinemic heart transplant recipients: results of a clinical trial E Sarmiento, P Diez, M Arraya, M Jaramillo, L Calahorra, ... Transplant Infectious Disease 18 (6), 832-843, 2016 | 26 | 2016 |
| Alterations of naïve and memory B‐cell subsets are associated with risk of rejection and infection in heart recipients N Lanio, E Sarmiento, A Gallego, L Calahorra, M Jaramillo, J Navarro, ... Transplant International 26 (8), 800-812, 2013 | 25 | 2013 |
| Monitoring of early humoral immunity to identify lung recipients at risk for development of serious infections: a multicenter prospective study E Sarmiento, J Cifrian, L Calahorra, C Bravo, S Lopez, R Laporta, ... The Journal of Heart and Lung Transplantation 37 (8), 1001-1012, 2018 | 19 | 2018 |
| Secondary antibody deficiency is associated with development of infection in kidney transplantation: Results of a multicenter study E Sarmiento, M Jimenez, M di Natale, M Rodriguez‐Ferrero, F Anaya, ... Transplant Infectious Disease 23 (2), e13494, 2021 | 9 | 2021 |
| Peripheral Myeloid-Derived Suppressor Cells are good biomarkers of the efficacy of Fingolimod in Multiple Sclerosis C Camacho-Toledano, I Machín-Díaz, L Calahorra, M Cabañas-Cotillas, ... Journal of Neuroinflammation 19 (1), 1-22, 2022 | 8 | 2022 |
| Potential role of serum BAFF as a biomarker in HIV infection J Carbone, L Calahorra, J Navarro, E Sarmiento Infectious Diseases 47 (4), 260-262, 2015 | 6 | 2015 |
| Central and peripheral myeloid-derived suppressor cell-like cells are closely related to the clinical severity of multiple sclerosis MC Ortega, R Lebrón-Galán, I Machín-Díaz, M Naughton, I Pérez-Molina, ... Acta Neuropathologica, 1-20, 2023 | 3 | 2023 |
| CIRCULATING MYELOID-DERIVED SUPPRESSOR CELLS AS A POTENTIAL BIOINDICATOR OF THE ENDOGENOUS MYELIN REPAIR CAPACITY IN EXPERIMENTAL MULTIPLE SCLEROSIS MP Serrano-Regal, I Alonso-García, C Camacho-Toledano, I Machin-Diaz, ... IBRO Neuroscience Reports 15, S290-S291, 2023 | | 2023 |
| EVOBRUTINIB TREATMENT REDUCES THE DAMAGE TO THE CNS AND INCREASES THE NUMBER OF CLASSICAL DENDRITIC CELLS IN EXPERIMENTAL MULTIPLE SCLEROSIS MP Serrano-Regal, L Calahorra, I Alonso-García, U Boschert, ... IBRO Neuroscience Reports 15, S272-S273, 2023 | | 2023 |
| MYELOID-DERIVED SUPPRESSOR CELL BURDEN IN THE CNS AND BLOOD IS ASSOCIATED WITH DISEASE SEVERITY OF MULTIPLE SCLEROSIS PATIENTS MC Ortega, I Machin-Diaz, M Naughton, I Pérez-Molina, J García-Arocha, ... IBRO Neuroscience Reports 15, S285-S286, 2023 | | 2023 |
| Circulating monocytic myeloid-derived suppressor cells but not Treg are potential biomarkers of a full relapse recovery in untreated multiple sclerosis patients LC Melero, I Machin-Diaz, I Alonso-Garcia, IP Molina, ... MULTIPLE SCLEROSIS JOURNAL 29, 562-563, 2023 | | 2023 |
| Evobrutinib therapeutic response is associated with an increase in the number and maturation of peripheral and central classical dendritic cells (P7-3.005) D Clemente, MP Serrano-Regal, L Calahorra, I Alonso-García, ... Neurology 100 (17 Supplement 2), 2023 | | 2023 |
| Evobrutinib exerts a therapeutic action on EAE by increasing the peripheral and central classical dendritic cell number and maturation MP Serrano-Regal, L Calahorra, IA Garcia, R Grenningloh, U Boschert, ... MULTIPLE SCLEROSIS JOURNAL 28 (3_ SUPPL), 342-342, 2022 | | 2022 |
| Shedding light on the variability of the clinical course of multiple sclerosis: analysis of the influence of myeloidderived suppressor cells on disease severity MC Ortega, J Garcia-Arocha, R Lebron-Galan, I Machin-Diaz, ... MULTIPLE SCLEROSIS JOURNAL 28 (3_ SUPPL), 163-164, 2022 | | 2022 |
| Circulating myeloid-derived suppressor cells as a potential biomarker of an anti-inflammatory T-cell balance associated with improved relapse recovery in multiple sclerosis L Calahorra, I Machin-Diaz, I Alonso, I Perez-Molina, ... MULTIPLE SCLEROSIS JOURNAL 28 (3_ SUPPL), 829-829, 2022 | | 2022 |
| B Cell Abnormalities and Cancer Development in Heart Recipients K Limay, N Jimenez, A Gallego, E Zatarain, I Sousa, A Alarcon, ... The Journal of Heart and Lung Transplantation 40 (4), S199, 2021 | | 2021 |
| Pre Transplant Interleukin 10 Levels are Higher in Lung Recipients with Post Transplant Infections L Calahorra, E Sarmiento, J Cifrian, C Bravo, R Laporta, M Ussetti, ... The Journal of Heart and Lung Transplantation 38 (4), S220-S221, 2019 | | 2019 |
| Estudio del estado de maduración del linfocito B y factores solubles asociados a rechazo e infección en pacientes sometidos a trasplante de órgano sólido L Calahorra Melero Universidad Complutense de Madrid, 2018 | | 2018 |
